Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
Status:
Completed
Trial end date:
2017-04-26
Target enrollment:
Participant gender:
Summary
This clinical trial is designed to prove the efficacy and safety of Fexinidazole as an oral
treatment for human african trypanosomiasis in advanced stage. The Fexinidazole is compared
to reference treatment NECT. The trial will try to demonstrate that Fexinidazole is not
inferior to NECT treatment.